Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation.
Jenny M NorlinMichael WillisUlf PerssonEmelie AnderssonSven E PålhagenPer OdinPublished in: Acta neurologica Scandinavica (2021)
Three years after the guidelines were published, the use of device-aided therapies has increased in Sweden, albeit not in pace with recommendations. One reason for slow implementation may be poor incentivization related to budget silos in which the costs for device-aided therapies are borne by the regions but the cost offsets (eg, reduced need for home care) are reaped by local stakeholders.